标题
Targeting ApoC-III to Reduce Coronary Disease Risk
作者
关键词
Triglycerides, Triglyceride-rich lipoproteins, CAD, apoC-III, PPAR, Statin, Niacin
出版物
Current Atherosclerosis Reports
Volume 18, Issue 9, Pages -
出版商
Springer Nature
发表日期
2016-07-21
DOI
10.1007/s11883-016-0609-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results
- (2016) Xiaohong Yang et al. JOURNAL OF LIPID RESEARCH
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo
- (2015) Raymond E. Soccio et al. CELL
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Nonstatin Therapies for Management of Dyslipidemia: A Review
- (2015) Karen R. Sando et al. CLINICAL THERAPEUTICS
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Physiological regulation of lipoprotein lipase
- (2014) Sander Kersten BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
- (2014) Raymond E. Soccio et al. Cell Metabolism
- The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management Recommendations
- (2014) Anandita Agarwala et al. Current Atherosclerosis Reports
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
- (2014) Ron Do et al. NATURE
- Resurgence of targets and compounds to treat dyslipidaemia
- (2014) John J. P. Kastelein Nature Reviews Cardiology
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial
- (2014) Todd J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in pharmacotherapy for hypertriglyceridemia
- (2014) Amirhossein Sahebkar et al. PROGRESS IN LIPID RESEARCH
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Common variants associated with plasma triglycerides and risk for coronary artery disease
- (2013) Ron Do et al. NATURE GENETICS
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease
- (2012) Seung-Kwon Myung ARCHIVES OF INTERNAL MEDICINE
- Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
- (2012) G. Reyes-Soffer et al. DIABETES CARE
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events
- (2012) Evangelos C. Rizos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression
- (2012) B. Lauring et al. Science Translational Medicine
- Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis
- (2011) Eric A. Schwartz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Vascular Disease Risk in Patients With Hypertriglyceridemia: Endothelial Progenitor Cells, Oxidative Stress, Accelerated Senescence, and Impaired Vascular Repair
- (2011) Eric Thorin CANADIAN JOURNAL OF CARDIOLOGY
- Missense Mutation inAPOC3within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins
- (2011) Wen Qin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia
- (2011) Kevin C. Maki et al. Journal of Clinical Lipidology
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The Effects of Nicotinic Acid, Phentolamine and Nethalide on the Plasma Free Fatty Acids and the Blood Pressure in the Dog A Comparative Study
- (2010) Sven Fröberg et al. ACTA MEDICA SCANDINAVICA
- Inhibition of the Mobilization of Free Fatty Acids from Adipose Tissue in Diabetes
- (2010) LARS A. CARLSON et al. ACTA MEDICA SCANDINAVICA
- Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control
- (2010) Vincent J. Carey et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of atorvastatin and n−3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity
- (2010) Dick C Chan et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
- (2010) Carlos Hernandez et al. Cell Metabolism
- Functional analysis of the missenseAPOC3mutation Ala23Thr associated with human hypotriglyceridemia
- (2010) Meenakshi Sundaram et al. JOURNAL OF LIPID RESEARCH
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease
- (2009) Ole Faergeman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Thiazolidinediones and the liver in humans
- (2009) Hannele Yki-Järvinen CURRENT OPINION IN LIPIDOLOGY
- Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
- (2009) M. Sundaram et al. JOURNAL OF LIPID RESEARCH
- Atorvastatin and Fenofibrate Have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men With the Metabolic Syndrome
- (2008) Dick C. Chan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Kinetic Studies of the Metabolism of Rapidly Exchangeable Apolipoproteins May Leave Investigators and Readers With Exchangeable Results
- (2008) Henry N. Ginsberg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
- (2008) Yasushi Saito et al. ATHEROSCLEROSIS
- Dose-Dependent Effect of Rosuvastatin on VLDL-Apolipoprotein C-III Kinetics in the Metabolic Syndrome
- (2008) E. M.M. Ooi et al. DIABETES CARE
- Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial
- (2008) Michael Miller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
- Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
- (2007) Herbert Schuster et al. ATHEROSCLEROSIS
- Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
- (2007) Sander Kersten PPAR Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started